The webinar "Liver Tumors of Unidentified Primary: are all HCC or HCC-CCA?", organized by Hepatoma Research and chaired by Prof. Tania Roskams, Head of Department of Imaging and Pathology of Katholieke Universiteit Leuven and University Hospitals Leuven, has been held successfully on April 22, 2022.
Six outstanding international guest speakers delivered their excellent speeches and shared their new insights on different topics of HCC-CCA in the webinar.
Speaker 1: Prof. Tania Roskams, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
Topic: Histopathology of liver tumors: all primary and metastatic tumors
Speaker 2: Prof. Swan N. Thung, Professor of Pathology, Molecular and Cell-Based Medicine; Director of Hepatopathology Division, Icahn School of Medicine at Mount Sinai, New York, USA.
Topic: HCC Mimickers
Speaker 3: Prof. Vincent Vandecaveye, Professor at the Catholic University of Leuven; Supervising staff radiologist at the division of abdominal/gynecological imaging, Department of radiology, University Hospitals Leuven, Leuven, Belgium.
Topic: Radiological diagnosis of liver carcinoma
Speaker 4: Dr. Daniela Sia, Assistant Professor of Medicine, Liver Diseases, Liver Cancer Program, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Topic: Understanding liver tumors: new insights into molecular subtypes
Speaker 5: Dr. Cipriani Federica, Medical Doctor of Department of Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Topic: Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
Speaker 6: Dr. Jaekyung Cheon, Assistant Professor of Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Topic: Systemic therapy against combined HCC-CCA
In the discussion part, speakers and participants heatedly discussed several interesting questions on the most-faced challenges, which we believe will positively influence the current research on HCC-CCA.
Hepatoma Research thanks to the chair Prof. Tania Roskams and all guest speakers again for the substantial effort to make this webinar a great success.
Hepatoma Research will hold more webinars and we look forward to having more researchers join our future webinars!
For more wonderful webinars of the journal, please visit https://hrjournal.net/journal/webinar.